Yüklüyor......
Cardiac Complications in Immune Checkpoint Inhibition Therapy
Immune checkpoint inhibitors (ICIs) have changed the treatment landscape of advanced cancers. Unfortunately, these agents can induce a wide spectrum of immune-related adverse events (irAEs) through activation of immune responses in non-target organs, including the heart. As the clinical use of ICI t...
Kaydedildi:
| Yayımlandı: | Front Cardiovasc Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6351438/ https://ncbi.nlm.nih.gov/pubmed/30729114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00003 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|